| |
|
|
|
Kazia Therapeutics Ltd ADR  
|
|
11.53 -0.26 (-0.02%) |
09-28 16:00 |
|
Open: |
11.9 |
Pre close: |
11.79 |
Target:
|
14.00
|
|
High: |
11.9015 |
Low: |
11.16 |
Resistance:
|
11.99
14.00
|
|
Volume: |
25,983 |
Market Cap: |
152M |
Support:
|
10.18
 9.06
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
11.39
|
MACD |
MACD(12,26):
|
0.44 |
|
MA(20): |
10.74 |
Signal(12,26,9): |
0.37 |
|
MA(100): |
9.82 |
Stochastic Oscillator |
%K(14,3):
|
79.83  |
|
MA(250): |
9.68 |
%D(3): |
83.98 |
|
Average Volume(K) |
3-Month: |
81642
|
52-Week |
High:
|
15.85 |
|
10-Days: |
3812 |
Low: |
5.55 |
|
RSI |
RSI(14):
|
65.77 |
Change(%): |
70.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.040 |
Return on Equity (ttm) |
-59.0 |
Shares Out. (M) |
12.96 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-26.9 |
Shares Float (M) |
9.16 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-99.8 |
% Held by Institutions |
4.24 |
|
Forward EPS |
-1.258 |
Gross Profit (p.s.) |
0.076 |
Shares Short (K) |
22 |
|
Book Value (p.s.) |
2.510 |
EBITDA (p.s.) |
-0.916 |
P/E |
-11.09 |
|
Sales Per Share |
0.028 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.59 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-18.34 |
P/S |
411.09 |
|
Operating Margin |
-3563.68 |
Levered Free Cash Flow
(M) |
-7.12 |
P/CF |
-8.15 |
|
|
|
|
|
|
